| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58209a99602b20c360e8d2eb8b6bee97 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-541 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2014-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ff60c95a0e9b71517cc91b007433a50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d06cdee2691b290e169ea6177f3159a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8dbbc5ec8da16b4ef3ec463b4a10243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea68492d4e82640a1dc5eee85ee62aef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cae6bf7492866988dfa294eafd47875e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_623e89a145a3c1af363bd96c0f21155a |
| publicationDate |
2015-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201536291-A |
| titleOfInvention |
A method of treating multiple cancers using AXL/cMET inhibitor alone or in combination with other agents |
| abstract |
Described compoundsnThe use of □ or a salt thereof, alone or in combination with other therapeutically active agents, for the treatment of a particular cancer comprising any solid cancer or blood cancer that is overexpressed by AXL or c-Met. |
| priorityDate |
2013-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |